A carregar...

‘Striking the Right Balance’ in Targeting PPARγ in the Metabolic Syndrome: Novel Insights from Human Genetic Studies

At a time when the twin epidemics of obesity and type 2 diabetes threaten to engulf even the most well-resourced Western healthcare systems, the nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) has emerged as a bona fide therapeutic target for treating human metabolic disease. T...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Gurnell, Mark
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1847466/
https://ncbi.nlm.nih.gov/pubmed/17389771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2007/83593
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!